100 related articles for article (PubMed ID: 11132239)
21. Cyclopentenyl cytosine induces apoptosis and increases cytarabine-induced apoptosis in a T-lymphoblastic leukemic cell-line.
Verschuur AC; Brinkman J; Van Gennip AH; Leen R; Vet RJ; Evers LM; Voûte PA; Van Kuilenburg AB
Leuk Res; 2001 Oct; 25(10):891-900. PubMed ID: 11532523
[TBL] [Abstract][Full Text] [Related]
22. Cyclopentenyl cytosine and neuroblastoma SK-N-BE(2)-C cell line cells.
Slingerland RJ; Van Gennip AH; Bodlaender JM; Voûte PA; Van Kuilenburg AB
Eur J Cancer; 1995; 31A(4):627-31. PubMed ID: 7576983
[TBL] [Abstract][Full Text] [Related]
23. Cyclopentenyl cytosine (CPEC): an overview of its in vitro and in vivo activity.
Schimmel KJ; Gelderblom H; Guchelaar HJ
Curr Cancer Drug Targets; 2007 Aug; 7(5):504-9. PubMed ID: 17691910
[TBL] [Abstract][Full Text] [Related]
24. In situ cyclopentenyl cytosine infusion for the treatment of experimental brain tumors.
Viola JJ; Agbaria R; Walbridge S; Oshiro EM; Johns DG; Kelley JA; Oldfield EH; Ram Z
Cancer Res; 1995 Mar; 55(6):1306-9. PubMed ID: 7882327
[TBL] [Abstract][Full Text] [Related]
25. Antiproliferative effects of cyclopentenyl cytosine (NSC 375575) in human glioblastoma cells.
Agbaria R; Kelley JA; Jackman J; Viola JJ; Ram Z; Oldfield E; Johns DG
Oncol Res; 1997; 9(3):111-8. PubMed ID: 9220496
[TBL] [Abstract][Full Text] [Related]
26. Docetaxel enhances the cytotoxicity of cisplatin to gastric cancer cells by modification of intracellular platinum metabolism.
Maeda S; Sugiura T; Saikawa Y; Kubota T; Otani Y; Kumai K; Kitajima M
Cancer Sci; 2004 Aug; 95(8):679-84. PubMed ID: 15298732
[TBL] [Abstract][Full Text] [Related]
27. Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum.
Uslu R; Bonavida B
Cancer; 1996 Feb; 77(4):725-32. PubMed ID: 8616765
[TBL] [Abstract][Full Text] [Related]
28. Silybin and its bioavailable phospholipid complex (IdB 1016) potentiate in vitro and in vivo the activity of cisplatin.
Giacomelli S; Gallo D; Apollonio P; Ferlini C; Distefano M; Morazzoni P; Riva A; Bombardelli E; Mancuso S; Scambia G
Life Sci; 2002 Feb; 70(12):1447-59. PubMed ID: 11883719
[TBL] [Abstract][Full Text] [Related]
29. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R; Tanabe K; Inoue H; Toge T
Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
[TBL] [Abstract][Full Text] [Related]
30. Cyclopentenyl cytosine primes SK-N-BE(2)c neuroblastoma cells for cytarabine toxicity.
Bierau J; Van Gennip AH; Leen R; Helleman J; Caron HN; Van Kuilenburg AB
Int J Cancer; 2003 Jan; 103(3):387-92. PubMed ID: 12471622
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma.
Suzuki M; Shinohara F; Nishimura K; Echigo S; Rikiishi H
Int J Oncol; 2007 Dec; 31(6):1449-56. PubMed ID: 17982671
[TBL] [Abstract][Full Text] [Related]
32. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.
Esaki T; Nakano S; Tatsumoto T; Kuroki-Migita M; Mitsugi K; Nakamura M; Niho Y
Cancer Res; 1992 Dec; 52(23):6501-6. PubMed ID: 1423296
[TBL] [Abstract][Full Text] [Related]
33. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxicity of antitumor platinum complexes with L-buthionine-(R,S)-sulfoximine and/or etanidazole in human carcinoma cell lines sensitive and resistant to cisplatin.
Brooks SE; Korbut TT; Dupuis NP; Holden SA; Teicher BA
Cancer Chemother Pharmacol; 1995; 36(5):431-8. PubMed ID: 7634385
[TBL] [Abstract][Full Text] [Related]
35. Low-intensity ultrasound and microbubbles enhance the antitumor effect of cisplatin.
Watanabe Y; Aoi A; Horie S; Tomita N; Mori S; Morikawa H; Matsumura Y; Vassaux G; Kodama T
Cancer Sci; 2008 Dec; 99(12):2525-31. PubMed ID: 19018767
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
Rybak SM; Pearson JW; Fogler WE; Volker K; Spence SE; Newton DL; Mikulski SM; Ardelt W; Riggs CW; Kung HF; Longo DL
J Natl Cancer Inst; 1996 Jun; 88(11):747-53. PubMed ID: 8637029
[TBL] [Abstract][Full Text] [Related]
37. Potentiation of cisplatin cytotoxicity by 9-aminocamptothecin.
Goldwasser F; Valenti M; Torres R; Kohn KW; Pommier Y
Clin Cancer Res; 1996 Apr; 2(4):687-93. PubMed ID: 9816219
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
[TBL] [Abstract][Full Text] [Related]
39. Molecular-weight-dependent pharmacokinetics and cytotoxic properties of cisplatin complexes prepared with chondroitin sulfate A and C.
Zhang JS; Imai T; Suenaga A; Otagiri M
Int J Pharm; 2002 Jun; 240(1-2):23-31. PubMed ID: 12062498
[TBL] [Abstract][Full Text] [Related]
40. Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatin-resistant HST-1 human squamous carcinoma cell line.
Esaki T; Nakano S; Masumoto N; Fujishima H; Niho Y
Int J Cancer; 1996 Feb; 65(4):479-84. PubMed ID: 8621231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
